CAREMATIX INC.

Carematix is an AI-driven Remote Patient Monitoring (RPM) platform specializing in chronic care management and reimbursement optimization. The company provides FDA-cleared, cellular-enabled biometric devices (blood pressure monitors, weight scales, pulse oximeters, glucometers) paired with intelligent cloud-based software for care coordination and patient engagement. Carematix is the only RPM company audited by the FDA, combining hardware and software for seamless EMR integration and HIPAA-compliant workflows. The platform supports Remote Patient Monitoring (CPT codes 99453, 99454, 99457, 99458, 99445, 99470) and Advanced Primary Care Management (APCM) reimbursement, enabling healthcare providers to generate recurring revenue while reducing hospital readmissions and ER visits. Devices feature cellular connectivity (no Bluetooth pairing required), proprietary Guest Button functionality, and automated patient engagement through phone call reminders and customizable vital sign alerts. Carematix serves primary care practices, health systems, clinical trial sponsors, and specialty providers managing hypertension, heart failure, diabetes, and weight management. The platform has been deployed in clinical trials across 14 countries and supported by major healthcare organizations including Ochsner Health, Veterans Affairs, Novartis, and Innovaccer. Strong clinical evidence demonstrates improved blood pressure control, reduced 30-day hospital readmissions (40% reduction reported by Ochsner), enhanced patient compliance, and increased treatment satisfaction.